|
1
|
Bioeffect modeling and equieffective dose concepts in radiation oncology--terminology, quantities and units.
|
Radiother Oncol
|
2012
|
2.49
|
|
2
|
Transition in survival from low-dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser1981 activity.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.41
|
|
3
|
Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model.
|
Mol Cancer Ther
|
2004
|
1.30
|
|
4
|
The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.09
|
|
5
|
Effects of exposure to low-dose-rate (60)co gamma rays on human tumor cells in vitro.
|
Radiat Res
|
2002
|
0.98
|
|
6
|
Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
|
Radiat Res
|
2006
|
0.98
|
|
7
|
Toxicity from radiation in breast cancer.
|
Cancer Treat Res
|
2006
|
0.94
|
|
8
|
MIRD continuing education: Bystander and low dose-rate effects: are these relevant to radionuclide therapy?
|
J Nucl Med
|
2007
|
0.94
|
|
9
|
How to overcome (and exploit) tumor hypoxia for targeted gene therapy.
|
J Cell Physiol
|
2003
|
0.91
|
|
10
|
Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury.
|
Radiother Oncol
|
2011
|
0.91
|
|
11
|
Estimating the lowest detectable dose of ionizing radiation by the cytokinesis-block micronucleus assay.
|
Radiat Res
|
2013
|
0.90
|
|
12
|
International Conference on Advances in Radiation Oncology (ICARO): outcomes of an IAEA meeting.
|
Radiat Oncol
|
2011
|
0.89
|
|
13
|
Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.
|
J Thorac Oncol
|
2011
|
0.88
|
|
14
|
Education and training for radiation scientists: radiation research program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12-14, 2003.
|
Radiat Res
|
2003
|
0.86
|
|
15
|
Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo.
|
Int J Radiat Biol
|
2005
|
0.82
|
|
16
|
Radioprotection of lung tissue by soy isoflavones.
|
J Thorac Oncol
|
2013
|
0.82
|
|
17
|
Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.
|
Radiother Oncol
|
2013
|
0.82
|
|
18
|
Gene expression-based detection of radiation exposure in mice after treatment with granulocyte colony-stimulating factor and lipopolysaccharide.
|
Radiat Res
|
2011
|
0.82
|
|
19
|
Monitoring sunitinib-induced vascular effects to optimize radiotherapy combined with soy isoflavones in murine xenograft tumor.
|
Transl Oncol
|
2011
|
0.81
|
|
20
|
Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
|
Cancer Gene Ther
|
2005
|
0.80
|
|
21
|
The evaluation of low dose hyper-radiosensitivity in normal human skin.
|
Radiother Oncol
|
2004
|
0.80
|
|
22
|
B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer.
|
Cancer Lett
|
2011
|
0.80
|
|
23
|
Radiation-induced adaptive response is not seen in cell lines showing a bystander effect but is seen in lines showing HRS/IRR response.
|
Int J Radiat Biol
|
2009
|
0.80
|
|
24
|
Relationships among micronuclei, nucleoplasmic bridges and nuclear buds within individual cells in the cytokinesis-block micronucleus assay.
|
Mutagenesis
|
2013
|
0.79
|
|
25
|
"SABER": A new software tool for radiotherapy treatment plan evaluation.
|
Med Phys
|
2010
|
0.79
|
|
26
|
Characteristic 8 keV X rays possess radiobiological properties of higher-LET radiation.
|
Radiat Res
|
2010
|
0.77
|
|
27
|
Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils.
|
J Thorac Oncol
|
2015
|
0.77
|
|
28
|
A novel method of boron delivery using sodium iodide symporter for boron neutron capture therapy.
|
J Radiat Res
|
2010
|
0.77
|
|
29
|
Ultrafractionation does not improve the results of radiotherapy in radioresistant murine DDL1 lymphoma.
|
Strahlenther Onkol
|
2005
|
0.76
|
|
30
|
Differences in cytogenetic sensitivity to ionizing radiation in newborns and adults.
|
Radiat Res
|
2014
|
0.75
|
|
31
|
Dose escalation in prostate cancer using intensity modulated neutron radiotherapy.
|
Radiother Oncol
|
2011
|
0.75
|
|
32
|
Dose escalation using a hypofractionated, intensity-modulated radiation therapy boost for localized prostate cancer: preliminary results addressing concerns of high or low alpha/beta ratio.
|
Clin Genitourin Cancer
|
2009
|
0.75
|